Alik Farber, MD

Interim Chief and Chair, Radiology

Alik Farber
75 E. Newton St Collamore Building


Alik Farber, MD, MBA, is interim Chair of the Department of Surgery and Professor of Surgery and Radiology at the Boston University Chobanian & Avedisian School of Medicine. Dr. Farber is also interim Chief of the Department of Surgery at Boston Medical Center, where he is Associate Chief Medical Officer for Surgical Services and Chief of the Division of Vascular & Endovascular Surgery.

After earning his undergraduate degree from Brown University, Dr. Farber received his medical degree from Harvard Medical School. He completed residency in general surgery at Massachusetts General Hospital, a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center, and an endovascular surgery fellowship at Southern Illinois School of Medicine. He received an MBA from the Heller School for Social Policy and Management at Brandeis University.

Dr. Farber began his career in 1999 as a vascular surgeon in private practice at Cedars-Sinai Medical Center in Los Angeles. In 2005, he was recruited to Boston Medical Center as an attending vascular surgeon and joined the faculty of the Chobanian & Avedisian School of Medicine as an Assistant Professor, rising to full Professor in 2015. Throughout his tenure, Dr. Farber has been involved in diverse academic, clinical operational, and leadership roles.

Dr. Farber’s clinical practice focuses on peripheral artery disease. An internationally recognized authority on limb ischemia, he has been invited to contribute to multidisciplinary consensus statements and has lectured across the world on this topic. Dr. Farber has served as principal investigator (PI) for multiple clinical trials involving wound care, intermittent claudication, and deep-vein arterialization. Most recently he served as co-PI of the landmark Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial. Funded by the National Heart, Lung, and Blood Institute, this international, multicenter, randomized controlled trial compared traditional bypass surgery with endovascular treatment for patients with chronic limb threatening ischemia. More than 1,800 patients at 150 sites across North America, Europe, and New Zealand were enrolled, with results published in The New England Journal of Medicine in 2022. Dr. Farber, who chairs the BEST-CLI Publications Committee, continues to be actively involved in trial dataset analysis and research dissemination through the BEST-CLI Collaborative, funded by the Novo Nordisk Foundation.

A fellow of the American College of Surgeons and a distinguished fellow of the Society of Vascular Surgery, Dr. Farber frequently serves in leadership roles for professional organizations. Currently, he is Secretary of the Society for Clinical Vascular Surgery and Treasurer of both the New England Society for Vascular Surgery and the Massachusetts Chapter of the American College of Surgeons.

Dr. Farber has authored more than 260 peer-reviewed manuscripts and 30 book chapters, and has edited two textbooks. He has given more than 160 presentations in over 20 countries.

Other Positions

  • Professor, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
  • Associate Chief Medical Officer for Surgical Services , Boston Medical Center
  • Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
  • Professor, Vascular & Interventional, Radiology, Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • Harvard Medical School, MD
  • Brown University, BS


  • Published on 4/10/2024

    Menard MT, Farber A, Powell RJ, Rosenfield K, Conte MS, Hamza TH, Kaufman JA, Cziraky MJ, Creager MA, Dake MD, Jaff MR, Reid D, Sopko G, White CJ, Strong MB, van Over M, Chisci E, Goodney PP, Gray B, Kayssi A, Siracuse JJ, Choudhry NK. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization. Circulation. 2024 Apr 16; 149(16):1241-1253. PMID: 38597097.

    Read at: PubMed
  • Published on 4/8/2024

    D'Angelo O, Menard MT, Farber A. Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial. Ann Vasc Surg. 2024 Apr 08. PMID: 38599479.

    Read at: PubMed
  • Published on 3/25/2024

    Patrone L, Pasqui E, Conte MS, Farber A, Ferraresi R, Menard M, Mills JL, Rundback J, Schneider P, Ysa A, Abhishek K, Adams GL, Ahmad N, Ahmed I, Alexandrescu VA, Amor M, Alper D, Andrassy M, Attinger C, Baadh A, Barakat H, Biasi L, Bisdas T, Bhatti Z, Blessing E, Bonaca MP, Bonvini S, Bosiers M, Bradbury AW, Beasley R, Behrendt CA, Brodmann M, Cabral G, Cancellieri R, Casini A, Chandra V, Chisci E, Chohan O, Choke ETC, Chong PFS, Clerici G, Coscas R, Costantino M, Dalla Paola L, Dand S, Davies RSM, D'Oria M, Diamantopoulos A, Debus S, Deloose K, Del Giudice C, Donato G, Rubertis B, Paul De Vries J, Dias NV, Diaz-Sandoval L, Dick F, Donas K, Dua A, Fanelli F, Fazzini S, Foteh M, Gandini R, Gargiulo M, Garriboli L, Genovese EA, Gifford E, Goueffic Y, Goverde P, Chand Gupta P, Hinchliffe R, Holden A, Houlind KC, Howard DP, Huasen B, Isernia G, Katsanos K, Katzen B, Kolh P, Koncar I, Korosoglou G, Krishnan P, Kroencke T, Krokidis M, Kumarasamy A, Hayes P, Iida O, Alejandre Lafont E, Langhoff R, Lecis A, Lessne M, Lichaa H, Lichtenberg M, Lobato M, Lopes A, Loreni G, Lucatelli P, Madassery S, Maene L, Manzi M, Maresch M, Santhosh Mathews J, McCaslin J, Micari A, Michelagnoli S, Migliara B, Morgan R, Morelli L, Morosetti D, Mouawad N, Moxey P, Müller-Hülsbeck S, Mustapha J, Nakama T, Nasr B, N'dandu Z, Neville R, Noory E, Nordanstig J, Noronen K, Mariano Palena L, Parlani G, Patel AS, Patel P, Patel R, Patel S, Pena C, Perkov D, Portou M, Pratesi G, Rammos C, Reekers J, Riambau V, Roy T, Rosenfield K, Antonella Ruffino M, Saab F, Saratzis A, Sbarzaglia P, Schmidt A, Secemsky E, Siah M, Sillesen H, Simonte G, Sirvent M, Sommerset J, Steiner S, Sakr A, Scheinert D, Shishebor M, Spiliopoulos S, Spinelli A, Stravoulakis K, Taneva G, Teso D, Tessarek J, Theivacumar S, Thomas A, Thomas S, Thulasidasan N, Torsello G, Tripathi R, Troisi N, Tummala S, Tummala V, Twine C, Uberoi R, Ucci A, Valenti D, van den Berg J, van den Heuvel D, Van Herzeele I, Varcoe R, Vega de Ceniga M, Veith FJ, Venermo M, Vijaynagar B, Virdee S, Von Stempel C, Voûte MT, Khee Yeung K, Zeller T, Zayed H, Montero Baker M. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2024 Mar 25; 15266028241231745. PMID: 38523459.

    Read at: PubMed
  • Published on 2/17/2024

    Conte MS, Azene E, Doros G, Gasper WJ, Hamza T, Kashyap VS, Guzman R, Mena-Hurtado C, Menard MT, Rosenfield K, Rowe VL, Strong M, Farber A. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Feb 17. PMID: 38368997.

    Read at: PubMed
  • Published on 2/12/2024

    Nwachuku EC, Farber A. Open Surgical Therapy for Peripheral Artery Disease. Curr Cardiol Rep. 2024 Apr; 26(4):211-220. PMID: 38342801.

    Read at: PubMed
  • Published on 2/2/2024

    Kobzeva-Herzog AJ, Levin SR, Young S, McNamara TE, Alonso AG, Farber A, King EG, Siracuse JJ. Assessing Time to Removal of Tunneled Dialysis Catheters after Arteriovenous Access Creation. Ann Vasc Surg. 2024 May; 102:35-41. PMID: 38377711.

    Read at: PubMed
  • Published on 1/31/2024

    Farber A, Menard MT, Bonaca MP, Bradbury A, Conte MS, Debus ES, Eldrup N, Goodney P, Gupta PC, Hinchliffe RJ, Houlind KC, Kolh P, Kum SWC, Nordanstig J, Parikh SA, Patel MR, Patrone L, Sillesen H, Strong MB, Varcoe RL, Vega de Ceniga M, Venermo MA, Rosenfield K. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally. Br J Surg. 2024 Jan 31; 111(2). PMID: 38294083.

    Read at: PubMed
  • Published on 1/30/2024

    Forsyth A, Haqqani MH, Alfson DB, Shaikh SP, Brea F, Richman A, Siracuse JJ, Rybin D, Farber A, Brahmbhatt TS. Long-term outcomes of autologous vein bypass for repair of upper and lower extremity major arterial trauma. J Vasc Surg. 2024 Jan 30. PMID: 38301809.

    Read at: PubMed
  • Published on 1/17/2024

    Smeds MR, Cheng TW, King E, Williams M, Farber A, Chitalia VC, Siracuse JJ. Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access. J Vasc Surg. 2024 Apr; 79(4):925-930. PMID: 38237702.

    Read at: PubMed
  • Published on 12/16/2023

    Zhu M, Arinze N, Buitron de la Vega P, Alonso A, Levin S, Farber A, King E, Kobzeva-Herzog A, Chitalia VC, Siracuse JJ. High Prevalence of Adverse Social Determinants of Health in Dialysis Access Creation Patients in a Safety-Net Setting. Ann Vasc Surg. 2024 Mar; 100:31-38. PMID: 38110081.

    Read at: PubMed

View 344 more publications: View full profile at BUMC

View all profiles